Reply to: 'Severe bullous pemphigoid following Covid-19 vaccination resistant to rituximab and successfully treated with dupilumab' by Baffa et al.
Lanyu SunC BrazãoDora ManchaLuís Soares-AlmeidaPaulo FilipePublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2023)